From first symptoms to finding an effective treatment

The journey from experiencing the first symptoms of chronic myeloid leukemia (CML) to finding an effective treatment can be long, difficult, and painful, especially in low- and middle-income countries. That...

Fighting on despite unexpected standstill

This is the story of twin sisters, Kanitha and Kanoksri Kumphai from Thailand.  Like twins the world over, they were inseparable and continued to do most things together well into...

Max participates in the Malaysian Society of Hematology Annual Meeting – first post pandemic live conference

The Malaysian Society of Hematology’s annual meeting, held earlier this year, took on special significance as it was the first face-to-face conference since the start of the COVID-19 pandemic. Chairperson,...

Targeted Treatment for Advanced Breast Cancer Including CDK4/6 Inhibitor Therapy Reaches Patients in Mozambique for the First Time

Three women diagnosed with HER2- HR+ advanced breast cancer in Mozambique have begun treatment, with efforts underway to open access in eight additional countries  The Max Foundation leading initiative through...

The Max Foundation and International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Partner to Enhance the Care of CLL in Low- and Middle-Income Countries

iwCLL to provide training, medical, and programmatic guidance to support implementation of access program for innovative CLL therapy in 29 LMICs over the next three years SEATTLE, Washington – October...

The Max Foundation welcomes John Menapace as CFO/VP of Administration

We are delighted to announce that John Menapace has joined the Max Foundation as CFO/VP of Administration. John brings demonstrated business leadership to his new role with a background comprising...